¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ ¹× º¸Á¶ ·Îº¿ ½ÃÀå
Patient Monitoring and Assistance Robots
»óǰÄÚµå : 1536232
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 127 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ¡¤º¸Á¶ ·Îº¿ ½ÃÀåÀº 2030³â±îÁö 281¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 48¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ¡¤º¸Á¶ ·Îº¿ ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2023-2030³â¿¡ CAGR 28.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 281¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ Àå¾ÖÀÎ Áö¿ø ·Îº¿Àº CAGR 31.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 118¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÚÀ² À̵¿ ¹Ý¼Û ·Îº¿ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 28.9%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 13¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 27.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ¡¤º¸Á¶ ·Îº¿ ½ÃÀåÀº 2023³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 42¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³âÀÇ CAGRÀº 27.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 26.5%¿Í 24.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 19.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ ¸ð´ÏÅ͸µ¡¤º¸Á¶ ·Îº¿ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ȯÀÚ ¸ð´ÏÅ͸µ ¹× º¸Á¶ ·Îº¿Àº ȯÀÚ¿¡°Ô Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú Áö¿øÀ» Á¦°øÇÔÀ¸·Î½á ÀÇ·á ȯ°æ¿¡¼­ Ä¡·áÀÇ ÁúÀ» ³ôÀ̱â À§ÇØ °í¾ÈµÈ ÃÖ÷´Ü ÀåºñÀÔ´Ï´Ù. ÀÌ ·Îº¿Àº ÷´Ü ¼¾¼­, Ä«¸Þ¶ó, Åë½Å ½Ã½ºÅÛÀ» °®Ãß°í ÀÖÀ¸¸ç, Ȱ·Â ¡Èĸ¦ ÃßÀûÇϰí, ÀÌ»ó ¡Èĸ¦ °¨ÁöÇϰí, ÀÇ·áÁø¿¡°Ô ÀáÀçÀû ¹®Á¦¸¦ ½Ç½Ã°£À¸·Î °æ°íÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ À̵¿, º¹¾à °ü¸®, °³ÀÎÀ§»ý °ü¸® µî ȯÀÚÀÇ ÀÏ»ó»ýȰÀ» Áö¿øÇÔÀ¸·Î½á ÀÇ·áÁøÀÇ ºÎ´ãÀ» ´ú¾îÁÖ°í ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕÀ» ÅëÇØ ÀÌ ·Îº¿Àº °³º° ȯÀÚÀÇ ¿ä±¸¿¡ ÀûÀÀÇÏ°í °³ÀÎÈ­µÈ Ä¡·á¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ¹× º¸Á¶ ·Îº¿ÀÇ µµÀÔÀº È¿À²¼º, Á¤È®¼º ¹× ȯÀÚ ¸¸Á·µµ¸¦ Çâ»ó½ÃÅ´À¸·Î½á ÀÇ·á ÇöÀåÀ» Å©°Ô º¯È­½ÃÄ×½À´Ï´Ù. º´¿øÀ̳ª ¿ä¾ç½Ã¼³¿¡¼­ ·Îº¿Àº ȯÀÚÀÇ °Ç°­ »óŸ¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ¿© ½ÉÁ¤Áö, È£ÈíºÎÀü, Ç÷¾ÐÀÇ ±Þ°ÝÇÑ º¯È­ µîÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ¼öÁý ¹× ºÐ¼®À» ÅëÇØ Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖÀ¸¸ç, ÀÀ±Þ»óȲ¿¡¼­ ¸Å¿ì Áß¿äÇÑ Àǹ̸¦ °®½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ Áö¿ø ·Îº¿Àº ¿îµ¿ Àå¾Ö³ª ¸¸¼ºÁúȯÀ» °¡Áø »ç¶÷µéÀ» Áö¿øÇÏ¿© µ¶¸³¼º°ú »îÀÇ ÁúÀ» À¯ÁöÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ·Îº¿ÀÌ ÀÏ»ó ¾÷¹«¸¦ ÀÚµ¿È­ÇÔÀ¸·Î½á ÀÇ·á Àü¹®°¡´Â ȯÀÚ Ä¡·áÀÇ ´õ º¹ÀâÇϰí Áß¿äÇÑ Ãø¸é¿¡ ÁýÁßÇÒ ¼ö ÀÖ°Ô µÇ¾î Àüü ÀÇ·á ¼­ºñ½º Á¦°øÀÌ °³¼±µÉ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ ¸ð´ÏÅ͸µ ¹× º¸Á¶ ·Îº¿ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ù°, ¸¸¼ºÁúȯ Áõ°¡¿Í °í·ÉÈ­·Î ÀÎÇØ Áö¼ÓÀû ÀÌ°í ½Å·ÚÇÒ ¼ö Àִ ȯÀÚ ¸ð´ÏÅ͸µÀ» Á¦°øÇÒ ¼ö Àִ ÷´Ü ÇコÄÉ¾î ¼Ö·ç¼ÇÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ·Îº¿ °øÇÐ, AI ¹× ¼¾¼­ ±â¼úÀÇ ±â¼ú ¹ßÀüÀº ÀÌ·¯ÇÑ ·Îº¿ÀÇ ´É·Â°ú ±â´ÉÀ» Çâ»ó½ÃÄÑ ´õ¿í È¿°úÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. ÀçÅÃÄ¡·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÌ·¯ÇÑ ·Îº¿ÀÌ ÀüÅëÀûÀÎ ÀÓ»ó ÇöÀå ¹Û¿¡¼­ ¾çÁúÀÇ Ä¡·á¸¦ ÃËÁøÇÒ ¼ö ÀÖ´Ù´Â Á¡¿¡¼­ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ Ä¡·á °á°ú °³¼±°ú ÀÇ·áºñ Àý°¨¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ·Îº¿ ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, COVID-19 ÆÒµ¥¹ÍÀÇ ¿µÇâÀ¸·Î ÀÎÇØ ·Îº¿ ±â¼úÀÇ ÀÇ·á ºÐ¾ß ÅëÇÕÀÌ °¡¼ÓÈ­µÇ¸é¼­ »ç¶÷°úÀÇ Á¢ÃËÀ» ÃÖ¼ÒÈ­ÇÏ°í °¨¿° È®»êÀ» ¹æÁöÇÏ´Â µ¥ ÀÖÀ¸¸ç, ·Îº¿ ±â¼úÀÇ Á߿伺ÀÌ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. Á߿伺À» °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¸¶Áö¸·À¸·Î ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í Çõ½ÅÀûÀÎ ·Îº¿ ¿ëµµÀÇ °³¹ßÀÌ È¯ÀÚ ¸ð´ÏÅ͸µ ¹× º¸Á¶ ·Îº¿ ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÃÑ 86°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Patient Monitoring and Assistance Robots Market to Reach US$28.1 Billion by 2030

The global market for Patient Monitoring and Assistance Robots estimated at US$4.8 Billion in the year 2023, is expected to reach US$28.1 Billion by 2030, growing at a CAGR of 28.8% over the analysis period 2023-2030. Handicap Assistance Robots, one of the segments analyzed in the report, is expected to record a 31.4% CAGR and reach US$11.8 Billion by the end of the analysis period. Growth in the Autonomous Mobile Transport Robots segment is estimated at 28.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 27.2% CAGR

The Patient Monitoring and Assistance Robots market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.2 Billion by the year 2030 trailing a CAGR of 27.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 26.5% and 24.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.5% CAGR.

Global Patient Monitoring and Assistance Robots Market - Key Trends and Drivers Summarized

Patient monitoring and assistance robots are cutting-edge devices designed to enhance the quality of care in healthcare settings by providing continuous monitoring and support to patients. These robots are equipped with advanced sensors, cameras, and communication systems that allow them to track vital signs, detect anomalies, and alert healthcare providers to potential issues in real-time. Additionally, they can assist patients with daily activities, such as mobility, medication administration, and personal care, thereby reducing the burden on healthcare staff and improving patient outcomes. The integration of artificial intelligence (AI) and machine learning algorithms enables these robots to adapt to individual patient needs and deliver personalized care.

The implementation of patient monitoring and assistance robots has significantly transformed the healthcare landscape by enhancing efficiency, accuracy, and patient satisfaction. In hospitals and care facilities, these robots ensure continuous monitoring of patients' health, allowing for early detection of conditions such as cardiac arrest, respiratory failure, or sudden changes in blood pressure. This real-time data collection and analysis enable timely interventions, which can be critical in emergency situations. Furthermore, patient assistance robots support individuals with mobility impairments or chronic conditions, helping them maintain their independence and quality of life. By automating routine tasks, these robots free up healthcare professionals to focus on more complex and critical aspects of patient care, thus improving overall healthcare delivery.

The growth in the patient monitoring and assistance robots market is driven by several factors. Firstly, the increasing prevalence of chronic diseases and the aging population necessitate advanced healthcare solutions that can provide continuous and reliable patient monitoring. Technological advancements in robotics, AI, and sensor technology enhance the capabilities and functionalities of these robots, making them more effective and user-friendly. The rising demand for home healthcare and remote patient monitoring further propels market growth, as these robots can facilitate high-quality care outside traditional clinical settings. Additionally, the growing emphasis on improving patient outcomes and reducing healthcare costs encourages the adoption of robotic solutions. The impact of the COVID-19 pandemic has also accelerated the integration of robotic technology in healthcare, highlighting the importance of minimizing human contact and preventing the spread of infections. Lastly, increased investments in healthcare infrastructure and the development of innovative robotic applications support the expansion of the patient monitoring and assistance robots market.

Select Competitors (Total 86 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â